Background: Fine needle aspiration (FNA) of renal masses can distinguish between benign and malignant neoplasms in 73–94% of cases. Previous studies suggested the correct subclassification of renal cell carcinomas (RCCs) by cytomorphology can be achieved in up to 80% of cases. However, as RCCs become increasingly subclassified by molecular signatures, correct subclassification based on cytology alone is increasingly difficult. Design: Two FNA passes (2 stained with Diff-Quik® and 2 with the Papanicolaou method) were performed on all fresh nephrectomy specimens for a 1-year period. There were 30 cases in this study, with 29 primary renal tumors and 1 case of metastatic lung adenocarcinoma. Each case was assigned a random number and came with 2 slides (1 from each staining method). Eight cytopathologists were asked to provide a diagnosis and the World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading if applicable. Fleiss’ Kappa and Cohen’s Kappa equations were used to look at inter-rater variability. Results: When compared to the surgical pathology diagnosis, the average percent correct diagnosis for all cytopathologist was 35%. Chromophobe RCCs had the best average percent accuracy at 72% followed by clearcell RCC at 48%. Average accuracy for grading RCCs was 40%. Inter-rater variability among the cytopathologists for all RCC diagnoses was fair with a Fleiss’ Kappa coefficient of 0.28. For the WHO/ISUP grade, the weighted coefficient for each pathologist ranged from 0.11 to 0.45, ranging from fair to moderate, respectively. Conclusions: Renal tumors are difficult to classify on cytopathology alone. Core needle biopsy and ancillary studies are necessary if diagnosis will change management.

1.
Nguyen
GK
,
Akin
MR
.
Fine needle aspiration cytology of the kidney, renal pelvis, and adrenal
.
Clin Lab Med
.
1998
;
18
(
3
):
429
59, vi
.
2.
Dragoescu
EA
,
Liu
L
.
Indications for renal fine needle aspiration biopsy in the era of modern imaging modalities
.
Cytojournal
.
2013
;
10
:
15
. .
3.
Renshaw
AA
,
Lee
KR
,
Madge
R
,
Granter
SR
.
Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma
.
Acta Cytol
.
1997
;
41
(
4
):
987
94
. .
4.
Niceforo
J
,
Coughlin
BF
.
Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy
.
AJR Am J Roentgenol
.
1993
;
161
(
6
):
1303
5
. .
5.
Moch
H
,
Cubilla
AL
,
Humphrey
PA
,
Reuter
VE
,
Ulbright
TM
.
The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours
.
Eur Urol
.
2016
;
70
(
1
):
93
105
. .
6.
Guo
J
,
Tretiakova
MS
,
Troxell
ML
,
Osunkoya
AO
,
Fadare
O
,
Sangoi
AR
, et al.
Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients
.
Am J Surg Pathol
.
2014
;
38
(
11
):
1457
67
.
7.
Yang
P
,
Cornejo
KM
,
Sadow
PM
,
Cheng
L
,
Wang
M
,
Xiao
Y
, et al.
Renal cell carcinoma in tuberous sclerosis complex
.
Am J Surg Pathol
.
2014
;
38
(
7
):
895
909
. .
8.
Tjota
M
,
Chen
H
,
Parilla
M
,
Wanjari
P
,
Segal
J
,
Antic
T
.
Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study
.
Am J Surg Pathol
.
2020 Jul
;
44
(
7
):
943
54
. .
9.
Trpkov
K
,
Hes
O
,
Bonert
M
,
Lopez
JI
,
Bonsib
SM
,
Nesi
G
, et al.
Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women
.
Am J Surg Pathol
.
2016
;
40
(
1
):
60
71
. .
10.
Parilla
M
,
Kadri
S
,
Patil
SA
,
Fitzpatrick
C
,
Ritterhouse
L
,
Segal
J
, et al.
Integrating a large next-generation sequencing panel into the clinical diagnosis of gliomas provides a comprehensive platform for classification from FFPE tissue or smear preparations
.
J Neuropathol Exp Neurol
.
2019
;
78
(
3
):
257
67
. .
11.
Srigley
JR
,
Delahunt
B
,
Eble
JN
,
Egevad
L
,
Epstein
JI
,
Grignon
G
, et al.
The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia
.
Am J Surg Pathol
.
2013
;
37
(
10
):
1469
89
.
12.
Sika-Paotonu
D
,
Bethwaite
PB
,
McCredie
MR
,
William Jordan
T
,
Delahunt
B
.
Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma
.
Am J Surg Pathol
.
2006
;
30
(
9
):
1091
6
. .
13.
Kryvenko
ON
,
Jorda
M
,
Argani
P
,
Epstein
JI
.
Diagnostic approach to eosinophilic renal neoplasms
.
Arch Pathol Lab Med
.
2014
;
138
(
11
):
1531
41
. .
14.
Robila
V
,
Kraft
AO
,
Smith
SC
.
New entities, new technologies, new findings: a review of the cytologic features of recently established subtypes of renal cell carcinoma
.
Cancer Cytopathol
.
2019
;
127
(
2
):
79
97
. .
15.
Lew
M
,
Foo
WC
,
Roh
MH
.
Diagnosis of metastatic renal cell carcinoma on fine-needle aspiration cytology
.
Arch Pathol Lab Med
.
2014
;
138
(
10
):
1278
85
. .
16.
Lin
X
.
Cytomorphology of clear cell papillary renal cell carcinoma
.
Cancer Cytopathol
.
2017
;
125
(
1
):
48
54
. .
17.
Liu
J
,
Fanning
CV
.
Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens?
Cancer
.
2001
;
93
(
6
):
390
7
.
18.
Armah
HB
,
Parwani
AV
.
Perivascular epithelioid cell tumor
.
Arch Pathol Lab Med
.
2009
;
133
(
4
):
648
54
. .
19.
Crapanzano
JP
.
Fine-needle aspiration of renal angiomyolipoma: cytological findings and diagnostic pitfalls in a series of five cases
.
Diagn Cytopathol
.
2005
;
32
(
1
):
53
7
. .
20.
Weir
M
,
Pitman
MB
.
The vascular architecture of renal cell carcinoma in fine-needle aspiration biopsies. an aid in its distinction from hepatocellular carcinoma
.
Cancer
.
1997
;
81
(
1
):
45
50
. .
21.
Granter
SR
,
Perez-Atayde
AR
,
Renshaw
AA
.
Cytologic analysis of papillary renal cell carcinoma
.
Cancer
.
1998
;
84
(
5
):
303
8
. .
22.
Tretiakova
MS
,
Sahoo
S
,
Takahashi
M
,
Turkyilmaz
M
,
Vogelzang
NJ
,
Lin
F
, et al.
Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma
.
Am J Surg Pathol
.
2004
;
28
(
1
):
69
76
. .
23.
Tejerina
E
,
González-Peramato
P
,
Jiménez-Heffernan
JA
,
Vicandi
B
,
Serrano
A
,
López-Ferrer
P
, et al.
Cytological features of chromophobe renal cell carcinoma, classic type. a report of nine cases
.
Cytopathology
.
2009
;
20
(
1
):
44
9
. .
24.
Memeo
L
,
Jhang
J
,
Assaad
AM
,
McKiernan
JM
,
Murty
VV
,
Hibshoosh
H
, et al.
Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma
.
Am J Clin Pathol
.
2007
;
127
(
2
):
225
9
. .
25.
El-Shorbagy
SH
,
Alshenawy
HA
.
Diagnostic utility of vimentin, CD117, cytokeratin-7 and caveolin-1 in differentiation between clear cell renal cell carcinoma, chromophobe renal cell carcinoma and oncocytoma
.
J Microsc Ultrastruct
.
2017 Apr–Jun
;
5
(
2
):
90
6
. .
26.
Chevarie-Davis
M
,
Riazalhosseini
Y
,
Arseneault
M
,
Aprikian
A
,
Kassouf
W
,
Tanguay
S
, et al.
The morphologic and immunohistochemical spectrum of papillary renal cell carcinoma: study including 132 cases with pure type 1 and type 2 morphology as well as tumors with overlapping features
.
Am J Surg Pathol
.
2014
;
38
(
7
):
887
94
. .
27.
Egbert
ND
,
Caoili
EM
,
Cohan
RH
,
Davenport
MS
,
Francis
IR
,
Kunju
LP
, et al.
Differentiation of papillary renal cell carcinoma subtypes on CT and MRI
.
AJR Am J Roentgenol
.
2013
;
201
(
2
):
347
55
. .
28.
El Naili
R
,
Nicolas
M
,
Gorena
A
,
Policarpio-Nicolas
MLC
.
Fine-needle aspiration findings of Xp11 translocation renal cell carcinoma metastatic to a hilar lymph node
.
Diagn Cytopathol
.
2017
;
45
(
5
):
456
62
. .
29.
Mansouri
D
,
Dimet
S
,
Couanet
D
,
Terrier-Lacombe
MJ
,
Vasiliu
V
,
Khalifa
C
, et al.
Renal cell carcinoma with an Xp11.2 translocation in a 16-year-old girl: a case report with cytological features
.
Diagn Cytopathol
.
2006
;
34
(
11
):
757
60
. .
30.
Battelli
C
,
Cho
DC
.
mTOR inhibitors in renal cell carcinoma
.
Therapy
.
2011
;
8
(
4
):
359
67
. .
31.
Choueiri
TK
.
VEGF inhibitors in metastatic renal cell carcinoma: current therapies and future perspective
.
Curr Clin Pharmacol
.
2011
;
6
(
3
):
164
8
. .
32.
Shen
SS
,
Truong
LD
,
Scarpelli
M
,
Lopez-Beltran
A
.
Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?
Arch Pathol Lab Med
.
2012
;
136
(
4
):
410
7
. .
33.
Renshaw
AA
,
Gould
EW
.
Ancillary studies in fine needle aspiration of the kidney
.
Cancer Cytopathol
.
2018
;
126
(
Suppl 8
):
711
23
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.